

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 1000caps | 3 bottles | A$417.66 | A$1,392.16 A$1,252.94 Best Price Popular | |
| 1000caps | 2 bottles | A$459.85 | A$1,021.87 A$919.69 | |
| 1000caps | bottle | A$504.19 | A$560.22 A$504.19 |
Disclaimer: This information is for Australia and is not a substitute for professional medical advice. Consult a pharmacist or doctor for personalised guidance about dapsone and its use.
Dapsone (the generic name) is a systemic medicine in the sulfone class that acts against certain bacteria and also reduces inflammation in the skin. The term “sulfone” refers to a specific chemical group found in the medicine. It is used under medical supervision for selected skin and systemic conditions.
In clinical practice, dapsone is prescribed to support control of particular skin disorders and to complement other treatments. The exact mechanism varies by condition, but the medicine can modulate immune responses and protect skin from ongoing irritation in some diseases. This information describes general use and does not replace professional advice.
Oral tablets are taken by mouth, typically once daily or as directed by a clinician. The medication should be used only under prescription and careful monitoring to manage benefits and potential risks. Check the official patient information leaflet provided with the medicine for specifics on formulation and warnings.
Dapsone may be prescribed as part of a broader treatment plan. The clinician will consider individual health factors, including other medicines, pregnancy status, and any known sensitivities. If there is any concern about starting dapsone, a healthcare professional should be consulted before use.
Dermatitis herpetiformis is a chronic, intensely itchy skin condition characterised by blister-like lesions that can affect elbows, knees, buttocks, and shoulders. Dapsone has a role in reducing itching and rashes associated with this condition. The skin symptoms may improve with treatment, but ongoing management often includes other measures such as a gluten-free diet where relevant.
Historically, dapsone has been used in the management of certain forms of Hansen’s disease (leprosy) as part of a combination therapy. In Australia, treatment decisions depend on clinical assessment and public health guidelines, and the medicine is used under professional supervision because of potential side effects and interactions.
In some patients, dapsone may be used for other conditions as determined by a clinician. This can include specific inflammatory or infectious processes where a doctor judges that the benefits outweigh the risks. Always follow the prescription and discuss any other health concerns with a clinician.
Therapy with dapsone is not a universal option for all patients or all stages of a disease. The suitability depends on the individual medical history, current medications, and laboratory test results. If unsure whether dapsone is appropriate, consult a healthcare professional for an evaluation and alternatives if needed.
Before starting dapsone, a clinician will check that it is appropriate and safe for the patient. A complete medical history will be reviewed and any known drug allergies will be considered. Baseline laboratory tests are commonly performed to assess blood and organ function, and to screen for conditions that could be affected by the medicine.
G6PD deficiency screening is often recommended prior to initiation, because this genetic condition can increase the risk of certain blood-related side effects with dapsone. The test results help guide safety decisions and monitoring plans. If a deficiency is known or suspected, the clinician may choose a different treatment approach or arrange closer follow-up.
Instructions about the start of therapy will be provided, including the prescribed dose, frequency, and any required follow-up tests. It is important to disclose all current medications, vitamins, and supplements to the clinician to identify potential interactions. If any new health issues arise after starting therapy, the attending clinician should be informed promptly.
Check that the patient information leaflet supplied with the medicine is read and understood. If the dose or administration schedule requires clarification, consult a pharmacist or doctor before proceeding. Do not begin therapy without explicit professional guidance when there is any uncertainty.
The usual approach is to take dapsone exactly as prescribed by the clinician. The medicine is taken by mouth with a full glass of water. Food may help reduce stomach upset in some individuals, but follow the guidance given by the prescriber.
Let tolerance guide the choice of meal timing if advised by a clinician; do not change the timing or the dose without professional advice. If a dose is missed, the label instructions or clinician’s guidance should be followed. If there is any doubt, contact a pharmacist or doctor for advice on how to proceed.
Tablets should be swallowed whole unless the product information states otherwise. Do not crush or chew unless explicitly advised by a clinician, as altering the tablet can change how the medicine is absorbed and may increase side effects. The medicine should be stored according to the label’s instructions and kept out of reach of children.
If the prescriber provides a specific schedule (for example, once daily at a particular time), adhere to that schedule. Any uncertainty about dosing should be resolved with the dispensing pharmacist or the prescribing clinician before continuing therapy.
The response to dapsone varies with the condition being treated. Some individuals notice a gradual reduction in itching or rash over days to weeks, while others may take longer to see a clear improvement. Blood tests or clinical assessments may be used to monitor effectiveness and safety during early therapy.
Side effects may occur during the initial period. Most are mild and transient, but the clinician may adjust the dose or monitoring plan if necessary. Patients are advised to report unexpected symptoms or persistent adverse effects promptly to the healthcare team.
In some cases, improvements in symptoms may be modest or delayed. The treatment plan often includes additional therapies or lifestyle adjustments to support disease control. Ongoing communication with the clinician ensures that the treatment remains appropriate and effective.
Any changes in health status, such as new skin changes, fatigue, or changes in vision or mood, should be discussed with a healthcare professional. Regular follow-up appointments are typically arranged to review progress and safety data during the course of therapy.
Contact a clinician if new symptoms develop or if existing symptoms worsen. Seek urgent medical help for signs of a serious allergic reaction, such as widespread swelling, trouble breathing, or a sudden severe rash. These reactions require immediate attention.
Prompt communication is advised if there are signs of anemia (for example, pale skin, fatigue, dizziness), yellowing of the skin or eyes, dark urine, or abdominal pain. These symptoms may indicate potential blood or liver-related issues that require assessment. Do not assume these symptoms will resolve without evaluation.
Regular laboratory monitoring is often scheduled during treatment. If it becomes difficult to attend appointments or if laboratory results are delayed, inform the clinician to discuss alternatives or rescheduling. Always report any concurrent illness or new medications that may interact with dapsone.
In the event of planned surgical procedures or dental work, inform the treating clinician about dapsone therapy. Some procedures or antibiotics used perioperatively may interact with the medicine, potentially requiring adjustments. Decisions should be made by a healthcare professional to minimise risk.
Store dapsone tablets in their original packaging and keep them at room temperature away from light, heat, and moisture. Do not transfer the medicine to another container, as this can affect stability and dosing accuracy. Keep out of reach of children and pets.
Check the expiry date on the packaging before each use. Do not use tablets past their expiry date. If a tablet breaks or crumbles, consult the pharmacist to determine whether the broken portions remain safe to use or require disposal.
Disposal of unused or expired medicine should follow local guidelines. Do not flush tablets down the toilet or pour them into drains unless specifically advised. A pharmacist can provide safe disposal options and any local regulations that apply.
Handle the medicine with dry hands, and minimize handling of tablets that appear damaged. If there is any concern about the integrity of the product, contact the pharmacy for guidance. Proper storage and handling help maintain safety and effectiveness throughout the course of therapy.
Common, mild adverse effects may include stomach upset, dizziness, or headache. These should be monitored, with medical advice sought if they persist or worsen. If symptoms are bothersome, discuss possible strategies with a pharmacist or clinician to improve comfort while continuing therapy.
Serious adverse effects require immediate medical evaluation. Potential concerns include signs of anemia, severe skin reactions, liver-related symptoms (such as persistent vomiting or jaundice), or new on-going fever. Any of these should prompt urgent medical assessment and possible dose adjustment or a change in therapy.
Contraindications may include known hypersensitivity to dapsone or related substances, established severe anemia, or certain enzyme deficiencies that increase risk for adverse outcomes. Drug interactions may occur with other medications, including some antibiotics, anti-inflammatory medicines, and antimalarial therapies. A clinician can assess risks based on the full medical history and current medications.
Pregnancy and breastfeeding require careful consideration. The benefits and risks must be weighed by a clinician, and alternative options may be discussed if potential risks are present. The information provided here does not replace professional guidance during reproduction or infant care.
In older adults or people with other chronic health conditions, the safety profile and the need for monitoring may differ. A clinician may adjust the monitoring schedule or choose alternative therapies based on organ function and overall health status. Regular follow-up helps to ensure safe and effective treatment.
Allergic history and previous adverse drug reactions should be reviewed prior to starting dapsone. If a history of drug sensitivity exists, the clinician may perform additional assessments or select a different treatment approach. Patients should report previous reactions to medications during the consultation.
Considerations for those with liver or kidney impairment are important. Dose adjustments or monitoring strategies may be required, and professional guidance should be sought before continuing therapy. The treatment plan will reflect the patient’s organ function and clinical needs.
For individuals with genetic or metabolic conditions that affect red blood cells, G6PD status informs safety planning. If G6PD status is uncertain, testing may be recommended before initiation to reduce risk. The clinician will interpret test results in the context of the overall treatment plan.
When traveling with dapsone, carry the medication in its original packaging with the label intact. A copy of the prescription or a clinician’s letter may help with travel documentation if required by local rules. Always keep medicines secure and readily accessible while away from home.
Potential drug interactions should be considered before travel or when starting new over-the-counter products. Some OTC medications or supplements can interact with dapsone, affecting effectiveness or increasing adverse effects. A pharmacist can help review all medicines prior to departure.
Sun sensitivity is a possible issue for some people taking dapsone. Use sunscreen, protective clothing, and limit prolonged sun exposure as advised by the clinician. If a rash or skin irritation develops after sun exposure, seek medical advice promptly.
Inform healthcare providers about dapsone use before any new procedure or dental work. Antibiotics or anesthetics prescribed for procedures may interact with the medicine. A plan can be prepared to minimise risks and ensure a safe course of care during the visit.
Below are common questions patients ask about dapsone. The responses are for general information and do not replace professional medical advice. When in doubt, contact a pharmacist or clinician for personalised guidance.
Questions address practical, everyday scenarios such as travel, timing, and interactions with other medications or activities. Always follow the advice given by the prescribing clinician and the product leaflets.
For safety, check any new information with a healthcare professional, especially if pregnant, breastfeeding, or managing other health conditions. If the information here conflicts with the official leaflet, the leaflet and clinician take precedence.
Users should be aware that prescription status may vary by local rules. Some situations may require a prescription depending on local regulations. In all cases, professional oversight is advised when starting or stopping any medicine.
Pregnancy involves careful consideration of benefits and risks. In some circumstances, dapsone may be used if the condition being treated presents significant risks to the mother or fetus. The decision rests with the clinician after review of the specific medical history and alternatives. Do not start or continue therapy without professional advice.
Breast milk can contain small amounts of dapsone. The decision to continue breastfeeding depends on factors such as infant health and the expected benefit to the mother. A clinician can help assess whether breastfeeding is compatible with therapy and monitor the infant as needed.
Moderation is advised. Alcohol can interact with liver function or worsen certain side effects. The clinician may offer specific guidance based on liver health, other medications, and the condition being treated. If there is any doubt, seek guidance before consuming alcohol.
Crushing or splitting tablets is not routinely recommended unless explicitly advised by a clinician. Altering the tablet can affect how the medicine is absorbed and its effectiveness. If splitting or altering the dose is ever necessary, a pharmacist should provide precise instructions.
Response time depends on the condition and individual factors. Some symptoms may improve within a few days to weeks, while others may require longer periods of treatment. Progress should be reviewed with the clinician at follow-up appointments.
Many patients may use common analgesics with dapsone, but potential interactions exist. A clinician or pharmacist should review all medicines, including over-the-counter products, to ensure compatibility and avoid adverse effects. Report any unusual symptoms after starting a new combination.
If a dose is forgotten, take it as soon as remembered unless it is near the time for the next dose. Do not double the dose to make up for a missed one. If there is confusion, contact a pharmacist for concrete guidance based on the prescribed schedule.
Travel is possible with dapsone, but it is advisable to carry a copy of the prescription and a note from the clinician summarising the treatment. Check local rules for medication importation or possession, and keep the medicine in its original container to minimise questions at security or customs checks.
Photosensitivity is a reported effect for some individuals. Use sunscreen with high protection factor, wear protective clothing, and avoid prolonged sun exposure where possible. Seek medical advice if a skin reaction develops or worsens after sun exposure.
There are no universal food restrictions tied to dapsone, but certain dietary patterns or supplements may influence how the medicine is tolerated, particularly if liver or blood parameters are affected. Discuss diet and supplement use with a clinician to tailor advice to the specific health scenario.
G6PD deficiency can influence the risk of hemolytic reactions with dapsone. If known, the clinician may adjust the plan or choose alternatives. If G6PD status is unknown, testing may be advised before starting therapy. Do not assume safety without professional confirmation.
Impaired liver or kidney function can affect how the medicine is processed in the body. Dose adjustments or additional monitoring may be required. A clinician will determine the safest approach based on laboratory results and overall health status.
Disclose all medications, including dapsone, to the dentist. Some dental antibiotics or procedures may interact with dapsone or necessitate planning to minimise risks. The dental team can coordinate with the prescribing clinician if adjustments are needed.
Store in a cool, dry place away from direct sunlight. Keep the original packaging and label intact. Do not transfer to a pill organiser without confirming that it will not affect stability. If storage conditions change, seek guidance from a pharmacist.
Discontinuation should be guided by a clinician. Stopping suddenly can affect disease control or trigger withdrawal effects in some cases. A healthcare professional can provide a tapering plan or alternatives if a transition is needed.
Immunisations generally continue as advised, but certain vaccines may require timing considerations. Discuss upcoming vaccines with the clinician to determine whether any adjustments are needed to the treatment plan or monitoring schedule.
In the event of suspected overdose, seek urgent medical help. Do not wait for symptoms to appear. Contact an emergency service or go to the nearest hospital as directed by local guidance. Do not attempt to treat at home without professional instructions.
Laboratory tests may reflect the influence of dapsone or its metabolites on blood counts, liver function, or other parameters. Regular monitoring as advised by the clinician helps ensure safe use and timely detection of potential issues. Report unusual test results to a healthcare professional.
14–21 days. Free from A$279.23 .
5–9 days. A$41.88
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
